Low-dose tenecteplase versus standard-dose alteplase for acute ischaemic stroke: an Imaging-Based Efficacy Trial.

Trial Profile

Low-dose tenecteplase versus standard-dose alteplase for acute ischaemic stroke: an Imaging-Based Efficacy Trial.

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Dec 2016

At a glance

  • Drugs Tenecteplase (Primary) ; Alteplase
  • Indications Embolism and thrombosis; Stroke
  • Focus Therapeutic Use
  • Acronyms TAAIS
  • Most Recent Events

    • 13 Dec 2016 Results of pooled post-hoc analysis from TAAIS and ATTEST studies (n=146) published in the Circulation.
    • 22 Mar 2012 Results published in the New England Journal of Medicine.
    • 08 Feb 2012 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top